Table 1. Studies that Directly Compared Low- and Conventional-Dose CTs as First-Line Imaging Test for Diagnosing Appendicitis.
Study | Comparison | Study Type* | Population/Sample | Results | ||||
---|---|---|---|---|---|---|---|---|
Low-Dose CT/Contrast Material | Conventional-Dose CT/Contrast Material | Age (Years) | Clinical Presentation†‡ | Sample Size§ | Outcome | Low-Dose CT vs. Conventional-Dose CT | ||
Keyzer et al. 2004 [36] Radiology | 1–2 mSv | 5–7 mSv | Retrospectiveǁ | 16–74 | NS | 29/95¶ | AUC | 0.92–0.93 vs. 0.91–0.93 |
None | None | Scan each patient twice | Sensitivity, % | 97–100 vs. 97–100 | ||||
MRMC (2 readers) | Specificity, % | 80–94 vs. 82–94 | ||||||
Keyzer et al. 2009 [37] AJR Am J Roentgenol | 30 mAs eff and 120 kVp (simulated**) | 100 mAseff and 120 kVp | Retrospectiveǁ | 18–87 | NS | 33/131 †† | With IV contrast | |
With or without oral†† | With or without oral†† | Dose simulation | Sensitivity, % | 76–88 vs. 91 | ||||
MRMC (2 readers) | Specificity, % | 98–99 vs. 97–99 | ||||||
Without IV contrast | ||||||||
Sensitivity, % | 82–91 vs. 79–82 | |||||||
Specificity, % | 90–95 vs. 95 | |||||||
Seo et al. 2009 [38] AJR Am J Roentgenol | 4 mSv | 8 mSv | Retrospective | 15–83 | Typical and atypical | 78/207¶ | AUC | 0.98–0.99 vs. 0.97–0.98 |
None | IV | Scan each patient twice | Sensitivity, % | 98.7–100 vs. 100 | ||||
MRMC (2 readers) | Specificity, % | 95.3–96.9 vs. 93–96.9 | ||||||
Platon et al. 2009 [39] Eur Radiol | 1–2 mSv | 7–10 mSv | Retrospectiveǁ | 18–96 | NS | 37/86¶ | Sensitivity, % | 95 vs. 100 |
Oral | Oral and IV | Scan each patient twice | Specificity, % | 96 vs. 96 | ||||
MRMC (2 readers) | ||||||||
Kim et al. 2011 [40] Radiology | 2 mSv | 8 mSv | Retrospective | 15–40 | Typical and atypical | 95/257‡‡ | NAR, % | 4.5 vs. 1.9 |
IV | IV | Prospective image interpretation | APR, % | 33 vs. 13 | ||||
Before-and-after design | AUC | 0.96 vs. 0.97 | ||||||
Sensitivity, % | 90 vs. 89 | |||||||
Specificity, % | 92 vs. 94 | |||||||
Kim et al. 2012 [41] N Engl J Med | 2 mSv | 8 mSv | Prospective | 15–44§§ | Typical and atypical | 346/891‡‡ | NAR, % | 3.5 vs. 3.2 |
IV | IV | RCT | APR, % | 26.5 vs. 23.3 | ||||
AUC | 0.97 vs. 0.98 | |||||||
Sensitivity, % | 94.5 vs. 95.0 | |||||||
Specificity, % | 93.3 vs. 93.8 | |||||||
Kim et al. 2015 [42] Acta Radiol | 2 mSv | 4 mSv | Retrospectiveǁ | 15–82 | NS | 58/102¶ | AUC | 0.96–0.97 vs. 0.93–0.97 |
IV (portal phase) | IV (arterial phase) | Scan each patient twice | ||||||
IR | FBP | MRMC (2 readers) | ||||||
LOCAT Group 2017 [43] Lancet Gastroenterol Hepatol | 2 mSv | 8 mSv | Prospective | 15–44§§ | Typical and atypical | 1088/3074‡‡ | NAR, % | 3.9 vs. 2.7 |
IV | IV | RCT | APR, % | 34.7 vs. 31.2 | ||||
AUC | 0.983 vs. 0.986 | |||||||
Sensitivity, % | 97.1 vs. 98.0 | |||||||
Specificity, % | 95.8 vs. 94.0 | |||||||
Sippola et al. 2020 [60] Ann Surg | 3 mSv | 4 mSv | Prospective | 18–60 | NS | 49/57¶ | Accuracy, % | 79 vs. 80 |
IV | IV | Scan each patient twice | ||||||
MRMC (2 readers) |
*All studies except for that by the LOCAT Group were single-institutional studies, †In all studies, clinical presentation was described as suspected appendicitis, ‡If patients with typical presentation and/or patients with atypical presentation of appendicitis were included, §Number of confirmed appendicitis/number of patients undergoing CT, ∥Patients were included prospectively, but images were reviewed retrospectively, ¶Each patient underwent low- and then conventional-dose CTs, **Low-dose CT was simulated by adding noise to original scans, ††Patients were randomized into oral-contrast or no-oral-contrast group. Each patient underwent conventional-dose CT before and after IV contrast enhancement, ‡‡Each patient underwent either low- or conventional-dose, §§Inclusion criteria. APR = appendiceal perforation rate, AUC = area under the receiver operating characteristic curve, FBP = filtered back-projection, IR = iterative reconstruction, IV = intravenous, mAseff = effective mAs, MRMC = multireader multicase, NAR = negative appendectomy rate, NS = not specified, RCT = randomized controlled trial